US Drug Recall Register
Class III · Low risk Terminated Initiated Jul 28, 2015 (11 years ago)

Premier Value Loratadine Orally Disintegrating Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Superpotent Drug: Out Of Specification (OOS) result for Assay.

What was recalled

Premier Value Loratadine Orally Disintegrating Tablets, USP, 10 mg, 30-count tablets per box; Distributed by Chain Drug Consortium, 3301 NW Boca Raton Blvd. Suite 101, Boca Raton, FL 33431, NDC 68016-527-31, UPC 8 4098601899 2

Recalling firm
Ohm Laboratories, Inc.
NDC code
68016-527-31
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0033-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Loratadine recalls

See all
Class II · Moderate risk Terminated

Desloratadine Tablets USP 5mg a) 100 count

Reason CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.

Lupin Pharmaceuticals Inc. NDC 68180-153-01 D-0221-2024
Class III · Low risk Terminated

AllerClear D-24 hr

Reason Failed Moisture Limits

Sun Pharmaceutical Industries INC NDC 63981-724-15 D-0069-2022
Class II · Moderate risk Terminated

Children's Loratadine Oral Solution USP

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 51672-2131-8 D-0572-2021